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ABSTRACT 
          Listeria monocytogenes is an ubiquitous Gram-positive food borne pathogen. 
Ingestion of L. monocytogenes contaminated food can cause serious infections in 
immune-compromised persons. In addition to planktonic growth, this pathogen can also 
grow as biofilms under adverse conditions, which has been proved to be more resistant 
than its planktonic counterpart to various eradications, such as antibiotic treatments. 
Compared with the extensively studied intracellular replication mechanisms, L. 
monocytogenes biofilm developmental process is not well understood.  
          Our research group initiated a systemic study on the molecular mechanisms of L. 
monocytogenes biofilm formation. A whole genome-scale screening for functional factors 
involved in L. monocytogenes biofilm development was carried out by means of 
transposon mutagenesis in combination with microtiter plate assays. 14 mutants with an 
at least 50% decreased biofilm formation were selected from 10,000 transposon mutants. 
Transposon locations in these 14 mutants were identified through NEST-PCR and 
sequencing. The in-frame deletion mutant of two genes, lmo2553 and lmo2554, were 
generated and showed similar biofilm formation defects as the transposon mutant. The 
roles of these genes in L. monocytogenes biofilm development will be further pursued in 
the future. 
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CHAPTER ONE 
INTRODUCTION 
          Listeria monocytogenes, an ubiquitous Gram-positive food borne pathogen, has a 
wide distribution in the natural environment like water or soil, and is frequently 
associated with food contamination. As the etiological agent of listeriosis, its intracellular 
surviving mechanisms, which are primarily governed by the master transcriptional 
regulator PrfA[1-3], have been relatively well explored. It’s been proven by different 
groups that L. monocytogenes is biofilm formation capable as well. As known, biofilm is 
a special microbial community that attaches to either biotic or abiotic surfaces and grows 
as a coordinated sessile community. Extracellular polymeric substance (EPS) plays an 
important role in the maintainance of the complex biofilm structure. Compared with its 
planktonic counterpart, biofilm is more resistant to various environmental stress, such as 
antibiotic treatment, nutrient limitation, and physical elimination. This could be a serious 
problem for those frequently involved in food contamination while at the same time are 
biofilm-capable, such as L. monocytogenes. Since L. monocytogenes is a frequent food-
associated pathogen, during food processing, it has various access to attach to certain 
surfaces, for example, plastic containers or stainless steel benches, and develop biofilm. 
Once occured this will significantly increase the survival of this pathogen and pose a 
hazardous threatening of food safety.  
          Currently the developmental process of L. monocytogenes biofilm is not well 
understood. Some factors have been shown to be involved but the detailed functions and 
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regulatory networks still await elucidation. A better understanding about the molecular 
mechanisms adopted by this pathogen in biofilm growth will help with the identification 
of critical factors in this developmental process and potential targets for elimination of 
biofilm contamination. This could be beneficial for both researches focused on L. 
monocytogenes and industrial issues bothered by biofilm contamination.  
          This study attempted to address the molecular basis of L. monocytogenes biofilm 
formation by starting with a genome-wide screening for functional factors involved in 
biofilm development. Transposon mutagenesis was utilized in combination with 
microtiter plate assays. 14 mutants were selected from a total of 10,000 transposon 
mutants with an at least 50% decreased biofilm formation. The transposon location in 
these 14 mutants were identified through NEST-PCR and sequencing. The in-frame 
deletion mutant of two genes, lmo2553 and lmo2554, were constructed and the biofilm 
test showed that both have the similar biofilm defect as the transposon mutant.  
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CHAPTER TWO 
LITERATURE REVIEW 
Influences of Listeria monocytogenes as a food born pathogen 
          As an ubiquitous Gram-positive bacterium, L. monocytogenes exists almost 
everywhere in our environment. It is such a well-adapted bacterium that it can not only 
survive vigorously as saprophyte in animal feces or acid mine drainage, but also as 
intracellular pathogen in various mammalian hosts. It is able to cause serious infections in 
the newborns, elders, pregnant women and the immune-compromised people. As the 
etiological agent of listeriosis, it can cause meningoencephalitis, septicemia, placentitis, 
abortion, neonatal septicemia, febrile gastroenteritis and subclinical pyogranulomatous 
hepatitis[4]. 2500 cases of listeriosis occur annually in the US, among which 500 cases 
result in death[5]. L. monocytogenes is also a food-borne pathogen that is frequently 
associated with world-wide outbreaks and is under CDC surveillance.  A lot of different 
types of food can serve as prosperous niches for this pathogen, such as dairy 
products[6,7], meat[8], and sea food[9]. The contamination of this pathogen in food has 
always been a concern in the food industry, probably due to its highly evolved ability to 
survive unfavorable conditions. L. monocytogenes can replicate at 1°C[10], which is the 
refrigeration temperature for most refrigerated food, and it can survive over a pH range 
from 4.4 to 9.4[10], or in an environment with a water activity as low as 0.92[10]. These 
characteristics all contribute to its increasing chances to cause human infections.  
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          Contamination by L. monocytogenes can become a big economic concern as well, 
especially for food industry. There was a big recall of imported Manouri Cheese recently 
due to potential L. monocytogenes contamination[11]. Recalls of various products, such 
as sliced smoked salmon[12] and sprouts[13] were also associated with L. monocytogenes 
contamination. All these recalled products should be destroyed, and this could be a big 
economic loss for the company.  
Listeria monocytogenes PrfA regulon 
        As a model organism for the study of intracellular pathogenicity, the parasitic 
mechanisms of L. monocytogenes were extensively explored. The development of various 
genetic tools in the recent 30 years has facilitated the study of pathogenesis of this highly 
mortal pathogen[14-20]. The availability of genomic sequences of several strains 
dramatically accelerated the L. monocytogenes functional research[21]. L. monocytogenes 
pathogenicity is mainly mediated by  the Listeria Pathogeneity Island-1 (LIPI-1) (Figure 
2-1), the expression of which is precisely regulated by the master transcriptional factor 
PrfA[1-3]. The adaptation from a saprophyte to an intracellular pathogen requires the 
activation of PrfA and the subsequent induction of virulence factors[1,4,22,23].                    
 
Figure 2-1. Genetic scheme of L. monocytogenes Pathogenecity Island-1. The symbol
represents the terminator. 
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Figure 2-2. Intracellular life cycles of L. monocytogenes[28]. 
        As depicted in Figure 2-2, the intracellular life cycles of L. monocytogenes can be 
generally summarized into four stages. The first stage is the invasion of host cells, and for 
non-professional phagocytic cells this step is mediated by two bacterial surface proteins, 
internalin A (InlA) and internalin B (InlB)[24,25]. Upon entering the cytoplasm, the 
bacterium will be entrapped in a membrane-defined compartment called vacuole[4,22]. A 
successful intracellular infection will require the bacterial escape from the vacuole, which 
is the second stage of intracellular infection, by the function of bacterial hemolysin 
Listeriolysin O (LLO) and phospholipases[4]. Then bacterium will proceed to the third 
stage, which is cytosolic replication using all the nutrients from the cytosol. The fourth 
stage, cell-to-cell spread is mainly mediated by ActA protein, which plays a central role 
in the recruitment of host cell actin protein to generate the actin tail and enable the 
bacterium to move intracellularly[4,26,27]. A double-membrane vacuole is formed upon 
the invasion of the adjacent cell and the bacterium will repeat another intracellular life 
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cycle. This direct transmission among the host cells protects the bacterium from 
encountering the humoral immunity effector cells and molecules and increases the chance 
of successful infection.                               
          All the aforementioned virulence proteins are members of the PrfA regulon, under 
control of the positive regulatory factor PrfA, the gene of which is also located on the 
LIPI-1 downstream of the gene plcA (Figure 1-1). This 27 kDa protein belongs to the 
Crp/Cap regulatory protein family[29] and shares structural similarities with the 
enterobacterial regulator Crp (cAMP receptor protein). PrfA functions as a homodimer to 
bind to a palindromic promoter element tTAACanntGTtAa, named PrfA box[1], via the 
C-terminal helix-turn-helix (HTH) DNA binding motif. The monomer interaction occurs 
through the N-terminal domain including a β-roll and a long α-helix. Binding of this 
transcriptional activator will recruit the RNA polymerase to the targeted promoter region 
and initiate transcription[24]. PrfA was generally considered as essential for L. 
monocytogenes parasitism because prfA deletion mutants have been shown to be totally 
nonpathogenic due to the inability of virulence genes induction[24]. But a recent study on 
a low-virulence strain A23 did find that even without functional major virulence factors, 
such as the metalloprotease Mpl, internalin A, internalin B, and phospholipases, the strain 
could still form plaques and contaminate 100% of inoculate mice[30]. This indicates that 
this A23 strain might partially keep its virulence by some unidentified mutations[30].    
          PrfA regulation is well manipulated by L. monocytogenes at transcriptional, post-
transcriptional, and post translational levels[24]. Regulation at post translational level 
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mainly occurs through the changes of PrfA binding activity[1].  PrfA in the saprophytes 
normally exists in a native form which is weakly active, while binding to the unknown 
cofactor in the host cell will turn PrfA into the fully activated state[1]. Lots of study 
about various PrfA* mutants, such as Gly145Ser[31,32], Ile45Ser[33], Gly155Ser[34], 
Leu140Phe[35] and Glu77Lys[34], do prove that by mutation of specific amino acid 
outside of the HTH motif, PrfA can be locked on the highly active conformation and 
induce the PrfA-dependent virulence expression to a similar high level observed in the 
intracellular infection. In contrast, mutation inside the HTH motif significantly decreases 
the DNA binding affinity and leads to a loss of virulence[36]. In addition to this positive 
activating pathway, negative regulatory pathways have been found as well. One obvious 
evidence is the activated charcoal effect. It was well observed that adding activated 
charcoal to the culture medium can dramatically stimulate the virulence genes 
expression[37], and the adsorption of an unknown diffusible autorepressor by the 
activated charcoal was suspected to mediate this phenomenon. The other evidence of 
negative regulation is the observation that expression of virulence genes are 
downregulated in glucose or fructose supplemented medium even in the presence of 
activated charcoal[38-40]. This might suggest independent pathways for the sugar-
mediated regulation and autorepressor-mediated regulation.  
          It was well proven that prfA can be transcribed as both monocistronic and 
bicistronic[42,43]. Two promoters, PprfAP1 and PprfAP2, as shown in Figure 2-3, exist in 
the intergenic region between prfA and plcA. PprfAP1 is a σA-dependent promoter which 
is responsible for the low level PrfA synthesis in the normal environmental setting 
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bacteria[1], while PprfAP2 can be regulated by both σA and σB and mainly mediates the 
elevation of virulence expression under stress conditions[1,44]. The 5’ untranslated 
region (UTR) of transcripts generated from PprfAP1 promoter can form a secondary 
structure at low temperature such as 30°C to work as a thermosensor[45]. This secondary 
structure will only melt at high temperature, for example 37°C which is the normal 
human body temperature, and reveal the ribosome binding site at the 5’ UTR for PrfA 
translation. This might partially explain the rapid PrfA-dependent virulence induction 
upon host infection. prfA can also be transcribed as a bicistronic transcript from the PplcA 
(Figure 2-3), and since PplcA is PrfA-dependent, it has a positive feedback on PrfA 
synthesis. 
 
Figure 2-3. The organization of the three promoters that control the prfA transcription[41]. 
Square labeled A represents the recognition site for σA factor, and square labeled B 
represents the recognition site for σB factor. 
          Distinctive PrfA binding affinity to different promoters could be another way to 
manipulate PrfA regulation. More PrfA are required for activation of those promoters 
with mismatches in the PrfA box than those exactly matched promoters[46,47]. And the 
RNA polymerase (RNAP) binding affinity of the promoters could also plays a role in the 
expression regulation of the PrfA-dependent virulence genes[1].  
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           As the master regulator of L. monocytogenes, PrfA was considered as the critical 
regulator that mediates the transition from the extracellular free-living motile life style to 
the intracellular pathogen. But a very recent study from Kolter’s group just provided solid 
evidence for the idea that PrfA also contributes to biofilm formation, and is involved in 
the transition from the extracellular free-living style to the biofilm style[41]. prfA mutants 
were defective  in biofilm formation after initial surface adhesion[41], and the PrfA 
conformational change for biofilm formation is different from those required for 
intracellular virulence expression[41]. It would be interesting to investigate the molecular 
mechanisms of PrfA biofilm promotion.  
Bacterial biofilms 
          Biofilm is generally considered as an aggregate of microbial cells that attaches to 
either biotic or abiotic surfaces and grows as a matrix-encased community. Naturally 
occurred biofilm usually consists of mixed species populations, and this provides the 
growing community two advantages, a reciprocal balance in the whole community when 
the nutritional condition is altered due to the different physiological metabolism 
properties of the mixed population [48], and increased overall biofilm fitness due to the 
cooperation between these species through their various properties in cellular attachment, 
matrix synthesis, dispersal, motility and toxin production[48]. Both Gram-negative and 
Gram-positive bacteria, including L. monocytogenes, have been shown to be capable of 
biofilm growth on the surfaces of various materials.  
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          Through detailed study of biofilm development of various bacteria, a general five-
step developmental process has been proposed to govern the most bacterial biofilm 
formation[49].The first step is the initial attachment of single cells, which  usually is 
reversible and followed by the second step of irreversible attachment and beginning of 
extracellular polymeric substance (EPS), or the so-called matrix production. The 
mechanisms and mediators of the cell attachment have been a focus of biofilm research 
for a long time, and one good example is the role of flagellum. Flagellum was generally 
considered as required for initial cell attachment in E. coli[50], P. aeruginosa[51], and L. 
monocytogenes[52,53], although evidences of its inhibitory effect on cellular attachment 
were also found by other group[54], and whether it serves as a adhesion molecule or 
motility factor is still under debation.  As the matrix production continues and the matrix 
accumulates, the biofilm architecture begins to establish in the third step, and then 
become mature in the fourth step. The matrix plays an important role in the maintenance 
of the biofilm structure[55]. Proteins, exopolysaccharides, lipids, and nucleic acids have 
been identified as components of the extracellular matrix while their relative contribution 
to the whole community might vary among different species[49]. In L. monocytogenes, 
proteins[56] and extracellular nucleic[57] acids were identified to be two components of 
its biofilm matrix. Due to the importance of matrix in biofilm, enzymes such as 
glycosidases, proteases, or deoxyribonucleases that can degrade biofilm matrix have been 
proposed as potential methods to control or eliminate biofilm growth[58]. Studies with 
scanning confocal laser microscopy (SCLM) revealed that generally the sessile bacteria 
grow in matrix encased clusters which are separated by a network of open water channels 
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for the purpose of nutrient exchange[49]. While some species biofilms exhibit a 
mushroom-like 3D structure[49], L. monocytogenes biofilm shows a different type that 
consists a network of knitted chains[59]. Finally, cell dispersion is shown to be an 
important and regulated step in the homeostasis of the biofilm community[49]. It was 
recently reported that in P. aeruginosa, as the biofilm structure becomes mature, matrix-
free cavity would be formed inside the clusters and swimming cells will be released from 
this cavity at the dispersion stage[60]. This self-active dispersal process called 
seeding[58], is one of the three distinct modes of biofilm dispersion[58], the other two 
types including erosion, which usually refers to continuous release of small clusters of 
cells from the biofilm, and sloughing, which defines the sudden detachment of large 
portions of the biofilm[58].   
          Biofilm has been proposed as an integral phase of bacterial life cycle which is 
usually adopted when the bacteria confront unfavorable living conditions. It’s been 
extensively demonstrated that compared with its planktonic counterpart, biofilm is much 
more resistant to the environmental stress, such as nutritional limitation, antibiotic[61], 
detergent treatment[62], or organic acids treatment[63]. In addition to functioning as the 
penetration obstacle attributing to its complex architecture[49], the strategies adopted by 
this sessile group for increased antibiotic resistance have been revealed to include several 
conventional mechanisms, for example, chromosomal β-lactamase, up-regulated efflux 
pumps, and mutations in the antibiotic target molecules[64].  
Transcriptional regulation in biofilm development 
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          In Bacillus subtilis, the most thoroughly studied Gram-positive organism and also 
the close relative of L. monocytogenes, several transcriptional factors (Figure 2-4) have 
been revealed to affect the bacterial biofilm formation, especially in terms of the matrix 
production, through the precise regulation of their downstream genes expression. The 
main matrix components of B. subtilis biofilm are encoded by two operons, the 15-gene 
eps operon which encodes the enzymes involved in exopolysaccharides production[65], 
and the yqxM-sipW-tasA operon[66] which encodes the secreted matrix protein TasA. 
The eps operon and the tasA operon are both repressed by SinR[67], the master regulator 
for B. subtilis biofilm, and this repression is released by the interaction of SinR with the 
anti-repressor SinI[68]. While under normal conditions SinR is constitutively expressed 
in the bacterial community, SinI is under the positive control of Spo0A bistable 
switch[68]. Two other regulators, AbrB and Sigma H factor, are also involved in B. 
subtilis biofilm transcriptional regulation. AbrB works as a negative regulator for biofilm 
formation by repressing the expression of one putative secreted protein YoaW and the 
signal peptidase SipW[69], while AbrB expression is under the direct negative control of 
Spo0A [70]. In contrast, Sigma H factor is suggested to indirectly stimulate the biofilm 
formation by activation of Spo0A expression[69,71]. A recent interesting observation 
found that expression of the anti-repressor SinI will be turned on only in a subpopulation 
of the B. subtilis biofilm community, thus the derepression of yqxM-sipW-tasA operon 
and eps operon in this subpopulation actually provides matrix for the whole biofilm 
community[68]. This labor-division system enables the B. subtilis cells to incorporate 
various environmental signals, such as nutritional or stress signals, to coordinate various 
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physiological processes, such as sporulation, cannibalism and biofilm formation[72], 
through this complex regulatory network and provide itself the best survival strategy.  
  
 
Figure 2-4. The transcriptional regulation network in B. subtilis biofilm. 
          In L. monocytogenes, currently only one transcriptional regulator, DegU, has been 
directly proven to mediate biofilm formation. L. monocytogenes DegU is an orphan 
response regulator which binds to its own promoter and works as an auto-represser[73]. It 
also binds to the promoter of motB operon and positively regulates the expression of 
GmaR[73], which is the anti-repressor of flagellar synthesis. DegU plays a role in 
bacterial motility, chemotaxis, virulence and biofilm of several Gram positive 
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species[73,74]. Deletion of DegU led to reduced L. monocytogenes biofilm formation[73] 
and its indirect regulation on flagella was suggested to mediate its role in biofilm[75]. 
Considering the involvement of flagella in L. monocytogenes biofilm[52], it would be 
tempting to look at if some other factors, such as MogR which has been shown to 
regulate flagellum motility[76] and virulence[77], also has a role in biofilm formation. 
Further study on biofilm matrix might provide more hints to unravel the transcriptional 
regulation network of L. monocytogenes biofilm.  
Quorum sensing in biofilm 
          Quorum sensing (QS) generally refers to the bacterial inter-species or intra-species 
communication based on the population-dependent production and secretion of certain 
diffusible small compounds. The accumulation of these signal molecules would be 
detected when it reaches a threshold, and stimulates the cellular responses in forms of 
regulated gene expression and coordinated population behavior. Quorum sensing has 
been found in both Gram-positive and Gram-negative bacteria. Different types of 
molecules function as the “language”, and this communication actually mediates various 
physiological processes including bacterial pathogenesis[78], bacteriocin production[79], 
competency development[80], biofilm formation[81,82] and multidrug resistance[83,84].  
          In the Gram-positive Streptococcus pneumonia, the broadly studied competence 
signaling peptide (CSP) QS system was demonstrated to influence the biofilm growth[82]. 
CSP is an oligopeptide product of the com regulon. comA and comB encode the secretion 
apparatus for CSP, while comC encodes the CSP precursor. The accumulated CSP is 
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detected by ComD, a surface histidine kinase receptor for CSP, and the signal is 
transmitted through the response regulator ComE, which induces the com regulon[85]. 
The subsequent product ComX is a sigma factor that regulates the expression of several 
groups of downstream genes[86]. Initially the CSP QS was found to affect bacterial 
competence. Accumulation of CSP to the threshold stimulates a subpopulation of the 
bacterial community to lyse and release nucleic acid, which is taken up by the remaining 
cells[87]. Addition of CSP increases the DNA level in the matrix as well as the biofilm 
growth[88,89]. Considering the role of nucleic acid as a component of biofilm matrix, it 
was suspected that the effects of CSP on biofilm growth could be related with its 
induction of cell lysis and DNA release[90]. But the details of the coordination of these 
two distinct yet correlated bacterial population behaviors still await elucidation.  
          Acylhomoserine lactone (AHL), also known as autoinducer-1 (AI-1)[91], is one 
QS signal that is only found in the Gram-negative microorganisms currently. LuxI and 
LuxR mediate this AHL QS system. LuxI is the AHL synthase while LuxR is the 
cytoplasmic receptor for AHL and at the same time the transcriptional activator for 
downstream target genes[92]. When the cell density is low, AHL production level is low 
as well and not enough AHL can diffuse into the cytoplasm and bind to LuxR, thus the 
unstable LuxR will be degraded. Only when the cell density reaches a certain high level, 
AHL will be accumulated to a concentration high enough to bind to LuxR and stabilize as 
well as activate the downstream gene expression[92]. It was recently found that among 
the many operons affected by AHL, one is the rhlAB which controls rhamnolipids 
production[93]. Changes of rhamnolipids production by rhlAB mutation resulted in 
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dramatically altered biofilm structure from a mushroom-like to a flat, undifferentiated 
one[94]. This AHL QS system controls the bacterial colonization of eukaryotes[95], and 
is critical for successful interaction of Pseudomonas aeruginosa with the animal or plant 
tissues[96]. Absence of AHL results in decreased biofilm formation in Pseudomonas 
aeruginosa[97] and Yersinia pestis[91], and the homologous QS system in Pantoea 
stewartii was proven to affect biofilm formation by controlling the exopolysaccharide 
production and the cell adhesion[92].  
          Another broadly studied QS signal is the Autoinducer 2 (AI-2) that exists in both 
the Gram-positive and Gram-negative microorganisms[98-101]. AI-2 was initially 
discovered in Vibrio harveyi as the quorum sensing molecule to regulate 
bioluminescence[102]. AI-2 refers to the collection of cyclic derivatives of 4,5-
dihydroxy-2,3-pentanedione (DPD), which is a highly reactive metabolic by-product of 
the activated methyl cycle[103]. DPD production depends on two catalytic enzymes, Pfs 
and LuxS[104]. Pfs catalyzes the conversion of s-adenosyl homocysteine (SAH) into s-
ribosyl homocysteine (SRH), and LuxS catalyzes the conversion of SRH into DPD[104]. 
While this luxS-dependent AI-2 QS system has a negative regulation on the biofilm 
formation of Bacillus cereus and Staphylococcus epidermidis[98,99], it was reported to 
positively regulate Streptococcus mutans biofilm formation[105]. It also mediates the 
increase of Streptococcus anginosus biofilm in the presence of sub-MICs of 
antibiotics[103], and Streptococcus gordonii biofilm formation ability in a mixed-species 
environment with Porphyromonas gingivalis[106]. In L. monocytogenes biofilm, LuxS 
seems to play a negative role because deletion of LuxS leads to a denser biofilm[104,107]. 
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But addition of AI-2 molecules couldn’t restore the normal biofilm level. Instead, 
addition of the SRH was able to modify the biofilm growth[104]. The role of AI-2 in L. 
monocytogenes was suggested to limit to detoxification of SAH, and might be irrelevant 
to QS[104]. 
          In L. monocytogenes, one quorum sensing system that has been shown to be 
involved in biofilm formation is the agr system. This system is encoded by a four-gene 
operon which contains a two-component regulatory system by coding the histidine kinase 
AgrC and response regulator AgrA, a signal peptide AgrD and the enzyme AgrB 
involved in AgrD processing[108]. High level of signal peptide AgrD due to increased 
cellular population enables AgrD to bind to the histidine kinase AgrC, which activates the 
response regulator AgrA by phosphorylation[109]. Activated AgrA then turns on the 
regulation of the downstream genes, which currently are unclear in L. monocytogenes. 
The agr system plays a role in both S. aureus[110] and L. monocytogenes[108,111] 
biofilm. Deletion of the signal peptide AgrD or response regulator AgrA resulted in 
decreased biofilm, and the agr operon expression level change appeared during the 
biofilm development did not happen to the planktonic growth[108].  
          Considering the broad involvement of QS in biofilm formation, QS has been 
studied for its potential as the biofilm eradication target. Inhibitors and antagonists of the 
QS were evaluated for their possible effects and consequences on the whole community 
as well as individual cell[112].   
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CHAPTER THREE 
MATERIALS AND METHODS 
Strains, plasmids, oligonucleiotides and growth conditions 
          Strains, plasmids and oligonucleotides used in this study are listed in Table 3-1, 3-2 
and 3-3. E. coli was cultured in Luria-Bertani broth (LB) (Bacto, USA) at 37°C with 
vigorous shaking unless otherwise specified. Planktonic L. monocytogenes was cultured 
in Brain Heart Infusion medium (BHI) (Bacto, USA) at 37°C with vigorous shaking 
unless otherwise specified. L. monocytogenes biofilm were grown in LB medium or 
Hsiang-Ning Tsai medium (HTM) [113] at 37°C without shaking unless otherwise 
specified. In E. coli, 100 µg/ml ampicillin was used to select for ampicillin resistance, 25 
µg/ml chloramphenicol was used to select for chloramphenicol resistance, and 30 µg/ml 
kanamycin was used to select for kanamycin resistance. In L. monocytogenes, 200 µg/ml 
streptomycin was used to select for streptomycin resistance, 5 µg/ml erythromycin was 
used to select for erythromycin resistance, and 10 µg/ml chloramphenicol was used to 
select for chloramphenicol resistance. 
Determination of biofilm growth conditions 
          Bacterial overnight cultures were grown in 200 µl BHI medium in 96-well 
polystyrene plates at 37°C without shaking, then 5 µl of the overnight culture was 
transferred to 200 µl HTM or LB medium in 96-well polystyrene plates to grow biofilm. 
Biofilm cultures were incubated at either 37°C or 30°C without shaking for 24 h, 48 h or 
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72 h. For the biofilm test, the supernatant cultures were discarded and each well was 
washed with 250 µl PBS for 5 times. 210 µl of 1% crystal violet was added to each well 
to stain the attached cells for 1 h, followed by distill water wash for 5 times. Then 220 µl 
of 95% ethanol was added to each well and incubated at room temperature for 6 h. The 
absorbance of the ethanol solution at 570 nm was measured using the MULTISCAN EX 
plate reader (Thermo, PA, USA).  
Transposon mutagenesis 
          The competent cells of L. monocytogenes were prepared as follows. A 10 ml 
overnight culture of L. monocytogenes strain 10403S was grown in BHI at 37°C with 
vigorous shaking. Then 3 ml of the overnight culture was inoculated into 100 ml 
sucrose/BHI. The freshly inoculated culture was grown at 37°C with vigorous shaking 
until the OD.600 reaches 0.2. Then 100 µl penicillin G (10 mg/ml) was added to the 
culture, and the incubation was continued for 2 h more. Then the bacterial culture was 
centrifuged at 7000 rpm for 10 min at 4°C. After decanting the supernatant, the cell pellet 
was washed 3 times with the ice cold wash solution (1 mM HEPES/0.5M sucrose), once 
with 100 ml and twice with 50 ml. Finally the cells were resuspended in 250 µl of the ice 
cold wash solution (1 mM HEPES/0.5M sucrose), and flash frozen in 100 µl aliquots at -
80°C.  
          The transposon mutagenesis was performed as follows. 0.2 µg transposon plasmid 
pMC38[114] was used for the electrophoration of 100 µl 10403S competent cells at 1.8 
KV, 400Ω, 25µFad. The electroporated cells were recovered in 2 ml BHI (0.5M sucrose) 
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medium at 30°C for 2 h, and then were selected on BHI agar plates with 200 µg/ml 
streptomycin and 5 µg/ml erythromycin at 30°C for 48 h. Transformants on the plates 
were inoculated in 2 ml BHI medium with 5 µg/ml erythromycin and 10 µg/ml 
kanamycin and incubated at 30°C overnight. 50 µl of the overnight culture was 
transferred to a 10 ml BHI medium with 200 µg/ml streptomycin and 5 µg/ml 
erythromycin and the incubation was continued at 30°C for 2 h, and then the incubation 
temperature was shifted to 42°C to lose the plasmid on purpose and the incubation 
continued for 6 h. 100 µl of the 1:100 diluted culture was directly plated on BHI agar 
plates with 200 µg/ml streptomycin and 5 µg/ml erythromycin, and the transposon 
mutants on these plates were grown at 42°C overnight. 
Microtiter plate assay 
          The transposon mutants were grown in 200 µl BHI medium with 200 µg/ml 
streptomycin and 5 µg/ml erythromycin in 96-well polystyrene plates at 37°C overnight 
without shaking, and 5 µl of the overnight culture was transferred to 200 µl HTM 
medium in 96-well polystyrene plates for biofilm growth at 37°C for 48 h without 
shaking. For the biofilm test, the supernatant culture was discarded and each well was 
washed with 250 µl PBS for 5 times. 210 µl of 1% crystal violet was added to each well 
to stain the attached cells for 1 h, followed by distill water wash for 5 times. Then 220 µl 
of 95% ethanol was added to each well and incubated at room temperature for 6 h. The 
absorbance of the ethanol solution at 570 nm was measured using the MULTISCAN EX 
plate reader (Thermo, PA, USA).  
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Linkage test 
          U153 phage [115] was used for the transduction. First of all, transposon mutants 
were grown in LB medium with 200 µg/ml streptomycin and 5 µg/ml erythromycin at 
30°C until the OD.600 reached 0.2. U153 phage stock was diluted to 106~104 titration, 
and 100 µl of diluted phage solution was mixed with 100 µl transposon mutants culture 
and incubated at room temperature for 40 min. Then 3 ml LB soft agar (0.75% agar) was 
mixed with each phage-bacterium mixture and poured onto LB agar plates with 10 mM 
CaCl2 and 10 mM MgSO4, following by incubation at room temperature for 24 h.  
          The plaque layer of the LB agar plates was soaked in 1 ml TM buffer (10 mM Tris 
HCl pH7.5, 10 mM MgSO4) for 25 min, then a sterile spreader was used to screw up the 
plaque layer, and both the TM solution and pieces of plaque layer were collected in a 
sterile centrifuge tube. The mixture was vortexed vigorously, and then centrifuged at 
8000 rpm for 10 min. The supernatant was transferred to another sterile centrifuge tube, 
mixed with 1/10 Volume of chloroform, and kept at room temperature for 10 min after 
vigorous vortex. The supernatant was collected as the mutant phage stock.  
          100 µl of mutant phage stock was mixed with 200 µl L. monocytogenes 10403S 
culture which was grown in LB medium at 30°C, and incubated at room temperature for 
1 h. Then 3 ml BHI soft agar (0.75%) was mixed with the mixture and poured onto BHI 
agar plates with 10 mM sodium citrate and 5 µg/ml erythromycin. Plates were incubated 
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at 37°C for 2 h, and then another layer of BHI soft agar was added to the plates. The 
incubation was continued at 37°C for 48 h. Colonies growing on the plates were 
randomly selected for the biofilm test as previously described, and the biofilms of these 
colonies were compared with the wild type 10403S and the original transposon mutants.    
Probe preparation and southern blot 
          The probe for erythromycin resistance cassette in mariner transposon was 
amplified using pMC38 plasmid as the template and primer # 88 and # 89. The resulting 
PCR fragment was purified by QIAGEN QIAEX II purification kit. The purified product 
was labeled with Biotin 3’ End DNA Labeling Kit (Pierce, IL, USA, PROD # 89818) as 
follow: First of all 100 ng DNA probe was denatured by heating in boiling water for 5 
min. Then 50 µl of reaction mixture, which contained 10 µl of 5ҳ TdT Reaction Buffer, 5 
pmol final 3’-OH end of pre-denatured DNA probe, 5 µl of 5µM Biotin-11-UTP, 5 µl of 
2 U/µl diluted TdT and ultrapure water, was prepared by adding individual components 
to the same reaction tube. The mixture was incubated at 37°C for 30 min, and the reaction 
was stopped by adding 2.5 µl of 0.2M EDTA. The labeled DNA probe was purified with 
chloroform: isoamyl alcohol, heated at 100°C for 5 min and placed on ice for the 
subsequent hybridization.  
          The genomic DNA of the L. monocytogenes transposon mutants were prepared 
with Wizard genomic DNA isolation kit (Promega, WI, USA), and 5µg of genomic DNA 
was digested with Hind III (TaKaRa, Japan) at 37°C overnight. Then the digested DNAs 
were applied to 0.8% agarose gel and electrophoresed at 25 constant voltage for 10 hours. 
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After electrophoresis, the gel was acid-depurinated by 0.25N HCl and denatured with 
0.5M NaOH and 1.5M NaCl for 45min, then neutralized with 0.5M Tris and 1.5M NaCl 
for 45min. DNA was transferred to positively charged nylon membrane (GE, Canada, 
VCAT# NP0HYB0010) using a downward transfer apparatus. After transfering, DNA 
was cross-linked to the membrane using the UVP CL-1000 Ultraviolet Crosslinker 
(254nm, autosetting) (UVP, CA), and the membrane was incubated in pre-hybridization 
buffer (6ҳ SSC, 5ҳ Denhardt solution, 0.5% SDS, 100µg/ml denatured fish sperm DNA) 
at 55°C for 2 h. Then hybridization was performed using hybridization buffer (6ҳ SSC, 
0.5% SDS) with labeled DNA probe (30 ng per ml of hybridization buffer) at 55°C 
overnight. On the next day, the membrane was washed 3 times for 15 min per wash with 
gentle agitation using the 50°C preheated wash buffer (2ҳ SSC, 0.1% SDS). Then the 
signal was detected using Chemiluminescent Detection Kit (Pierce, IL, USA, PROD # 
89880) according to the provided protocol.  
Transposon localization 
          Arbitrary-Primed PCR, as described before[116], was utilized to identify the 
location of the transposon on the chromosome. First round PCR was performed using 
primer # 5 paired with # 7 or # 10 in a final volume of 25µl with fresh colony from BHI 
plates and Choice Taq Polymerase (Denville, NJ, USA), and PCR was performed under 
following conditions: 95°C for 2min; 25 cycles of 94°C for 30sec, 42°C for 45sec, 72°C 
for 1min; and a final extension at 72°C for 5min. Then 5µl of the 1:25 dilution of the first 
round PCR product was used as the template for the second round PCR. The second 
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round PCR was performed using primer # 6 paired with # 8 or # 11 in a final volume of 
25µl with Choice Taq Polymerase (Denville, NJ, USA) under the following conditions: 
95°C for 2min; 25 cycles of 94°C for 30sec, 45°C for 45sec, 72°C for 1min; and a final 
extension at 72°C for 5min. The amplified products were subjected to agarose gel (1%) 
electrophoresis. Fragments from the agarose gel were excised and purified by QiaEXII 
(Qiagen, Germany). The purified fragments were sent for sequencing (Genomic Institute, 
Clemson University) using primer # 9 or # 12. The obtained sequences were blasted 
using NCBI nucleotide blast program (http://blast.ncbi.nlm.nih.gov/BlastoCgi).  
Construction of in-frame deletion mutant 
          Various sets of primers (#37~#40 for lmo1256; #41~#44 for lmo2553; #45~#48 for 
lmo2554; #49~#52 for lmo1083) were used to amplify upstream fragment and 
downstream fragment of target genes using genomic DNA of 10403S as the template 
with High Fidelity Taq Polymerase (Roche, Switzerland) in a final volume of 25 µl. Then 
1 µl of upstream and downtream fragments were mixed and used as template for the 
Gene Splicing by Overlap Extension (gene SOEing)[117] as described before to generate 
in-frame deletion fragment. The amplified product was subjected to agarose gel (0.8%) 
electrophoresis, and purified by QiaEXII (Qiagen, Germany). The purified product was 
digested with EcoR I and Hind III restriction enzymes (TaKaRa, Japan). After 
purification with the QiaEXII (QIAGEN, Germany), the digested fragment was ligated 
with the pKSV7 plasmid[19], which was digested with the same restriction enzymes and 
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purified. E.coli  DH5α competent cells were transformed with the ligation products and 
selected for ampicillin resistance on LB plates.  
          High purity pKSV7-deleted fragment plasmids were isolated from the E. coli  
transformants using PureYield Plasmid Miniprep System (Promega, WI, USA). 
Electroporation was performed to transform the pKSV7-deleted fragment plasmids into 
10403S competent cells at 1.8 KV, 400 Ω and 25 µFad. Transformants were selected for 
chloramphenicol resistance on BHI agar plates. The integrants were selected by 
incubation at 42°C in BHI plates supplemented with 10µg/ml chloramphenicol. The 
plasmid containing the wild type copy of the corresponding gene after alleic exchange 
was removed by passaging the bacterial culture in the BHI medium without 
chloramphenicol at 30°C for 8~12 passages. The bacterial colonies spread on BHI plates 
were randomly selected and tested for chloramphenicol sensitivity. Chloramphenicol 
sensitive colonies were subjected to PCR using respective primers to confirm the deletion.  
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Table 3-1. Strains used in this study.  
 
 
Strains Genotype References
E.coli
DH5α
F
-
 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZ ΔM15 Δ(lacZYA-argF )U169, hsdR17(rK
-
 mK
+
), λ–
lab stock
CE49 pKSV7-∆1083 in DH5α this study
CE51 pKSV7-∆2553  in DH5α this study
CE52 pKSV7-∆2554  in DH5α this study
CE53 pKSV7-∆1256  in DH5α this study
L.monocytogenes
10403S a streptomycin resistant isolate of strain 10403, 1/2a serotype lab stock
NF-L943
PrfA G155S mutation in 10403S background with 
actA-gus-plc B transcriptional fusion
28
TM-1 transposon insertion at lmo0644  in NF-L943 background this study
TM-2 transposon insertion at lmo1262/lmo1263  in NF-L943 background this study
TM-6 transposon insertion at lmo2553/lmo2554  in NF-L943 background this study
TM-16 transposon insertion at lmo0707  in NF-L943 background this study
TMY-95 transposon insertion at lmo2205  in 10403S background this study
TMY-169 transposon insertion at lmo0734 in 10403S background this study
TMY-235 transposon insertion at lmo0106  in 10403S background this study
TMY-386 transposon insertion at lmo0086  in 10403S background this study
TMY-408 transposon insertion at lmo2534  in 10403S background this study
TMY-423 transposon insertion at lmo2535  in 10403S background this study
TMY-438 transposon insertion at lmo2529 in 10403S background this study
TMY-486 transposon insertion at lmo0676  in 10403S background this study
TMY-489 transposon insertion at lmo1370  in 10403S background this study
TMY-521 transposon insertion at lmo2229  in 10403S background this study
CL-9 ∆plcA  and ∆plcB   in 10403S 118
CL-10 ∆hly   in 10403S 119
CL-18 ∆i nlB  in 10403S 120
CL-19 ∆inlA   in 10403S 120
CL-25 ∆mpl   in 10403S 121
CL-35 ∆actA  in 10403S 122
CL-57 ∆prfA in 10403S 123
CL-59 ∆lmo1083  in 10403S this study
CL-60 ∆lmo1256  in 10403S this study
CL-61 ∆lmo2554  in 10403S this study
CL-62 ∆lmo2553  in 10403S this study
CL-63 ∆lmo2553  in 10403S this study
CL-64 ∆flaA  in 10403S 124
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Table 3-2. Plasmids used in this study. 
 
  
Plasmids Description References
pMC38 mariner transposon vector with Bsu PmrgA, ts ori 108
pKSV7 intergrational vector derived from pE194ts 14
pMC43 in-frame deletion of lmo1083  in pKSV7 this study
pMC45 in-frame deletion of lmo2553  in pKSV7 this study
pMC46 in-frame deletion of lmo2554  in pKSV7 this study
pMC47 in-frame deletion of lmo1256  in pKSV7 this study
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# Name Sequences Applications References
1 Marq112 5'-CGC CAG GGT TTT CCC AGT CAC GAC-3' FOR CHECKING AND SEQUENCING CLONES IN pKSV7 14
2 Marq113 5'-AGC GGA TAA CAA TTT CAC ACA GGA-3' FOR CHECKING AND SEQUENCING CLONES IN pKSV7 14
5 ARB1 5'-GGC CAC GCG TCG ACT AGT ACN NNN NNN NNN GTA AT-3' ARBITRARY PRIMER 1 FOR NESTED PCR 108
6 ARB2 5'-GGC CAC GCG TCG ACT AGT AC-3' ARBITRARY PRIMER 2 FOR NESTED PCR 108
7 Marq 255 5'-CAG TAC AAT CTG CTC TGA TGC CGC-3' MARINER LEFT END PRIMER FOR 1ST ROUND NESTED PCR 108
8 Marq 256 5'-TAG TTA AGC CAG CCC CGA CAC CCG-3' MARINER LEFT END PRIMER FOR 2ND ROUND NESTED PCR 108
9 Marq 257 5'-CTT ACA GAC AAG CTG TGA CCG TCT-3' MARINER LEFT END PRIMER FOR SEQUENCING 108
10 Marq 269 5'-GCT CTG ATA AAT ATG AAC ATG ATG-3' MARINER RIGHT END PRIMER FOR 1ST ROUND NESTED PCR 108
11 Marq 270 5'-TGT GAA ATA CCG CAC AGA TGC GAA-3' MARINER RIGHT END PRIMER FOR 2ND ROUND NESTED PCR 108
12 Marq 271 5'-GGG AAT CAT TTG AAG GTT GGT ACT-3' MARINER RIGHT END PRIMER FOR SEQUENCING 108
37 1256 up forward 5'-GGA ATT CTT AGC ATC TAC TTT GGC ATC C-3' FOR GENERATION OF lmo1256 IN FRAME DELETION this study
38 1256 up reverse 5'-GTA TTT TTA TGC TGT TTA TTG TTT CAT GCC CAT CTC TCC-3' FOR GENERATION OF lmo1256 IN FRAME DELETION this study
39 1256 down forward 5'-GGA GAG ATG GGC ATG AAA CAA TAA ACA GCA TAA AAA TAC-3' FOR GENERATION OF lmo1256 IN FRAME DELETION this study
40 1256 down reverse 5'-CCC AAG CTT AAA AAT ACC GTA ACA AAG AGG-3' FOR GENERATION OF lmo1256 IN FRAME DELETION this study
41 2553 up forward 5'-GGA ATT CTG GGC AGG CGG ATT TTC TTT TGG T-3' FOR GENERATION OF lmo2553 IN FRAME DELETION this study
42 2553 up reverse 5'-GAT TTT TTG GGA CGC TGT ATC TAC CTT TCA CTC CTT CGT TAA-3' FOR GENERATION OF lmo2553 IN FRAME DELETION this study
43 2553 down forward 5'-TTA ACG AAG GAG TGA AAG GTA GAT ACA GCG TCC CAA AAA ATC-3' FOR GENERATION OF lmo2553 IN FRAME DELETION this study
44 2553 down reverse 5'-AAC TGC AGC CTT CCA AGC ATA GCA CCC ATT AAA TA-3' FOR GENERATION OF lmo2553 IN FRAME DELETION this study
45 2554 up forward 5'-GGA ATT CGG GAT CTG TTT GTG AGT GC-3' FOR GENERATION OF lmo2554 IN FRAME DELETION this study
46 2554 up reverse 5'-GCC TAA CCA TAT TTC AGC ACC CTG ACC TTT TAC TTT TTC-3' FOR GENERATION OF lmo2554 IN FRAME DELETION this study
47 2554 down forward 5'-GAA AAA GTA AAA GGT CAG GGT GCT GAA ATA TGG TTA GGC-3' FOR GENERATION OF lmo2554 IN FRAME DELETION this study
48 2554 down reverse 5'-CCC AAG CTT ACT AAA AAG TTC AGC ACG ACC-3' FOR GENERATION OF lmo2554 IN FRAME DELETION this study
49 1083 up forward 5'-GCT CTA GAA TAA CCA CTC TCT TTC TGT G-3' FOR GENERATION OF lmo1083 IN FRAME DELETION this study
50 1083 up reverse 5'-GAT AGT TTC TTT AAT TCC TGT ATA AGT CAG CAA ATC TAA GTT TAC-3' FOR GENERATION OF lmo1083 IN FRAME DELETION this study
51 1083 down forward 5'-GTA AAC TTA GAT TTG CTG ACT TAT ACA GGA ATT AAA GAA ACT ATC-3' FOR GENERATION OF lmo1083 IN FRAME DELETION this study
52 1083 down reverse 5'-GGG GTA CCT TTT TTT CTA AAG CAA CT-3' FOR GENERATION OF lmo1083 IN FRAME DELETION this study
88 Marq254 5' - CGTGGAATACGGGTTTGCTAAAAG - 3'
INTERNAL OF ermC FOR AMPLIFICATION OF PROBE
 FOR SOUTHERN BLOT
108
89 Marq206 5' - TGTCAGACATATGGGCACACGAAAAACAAGT - 3' 
3'-END OF ermC FOR AMPLIFICATION OF PROBE
 FOR SOUTHERN BLOT
108
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CHAPTER FOUR 
RESULTS 
Optimization of biofilm growth conditions 
          In order to select the proper condition which can stimulate robust biofilm growth, 
various combinations of medium and temperature were tested for their ability to promote 
L. monocytogenes biofilm growth before the screening. After testing the wild type 
10403S biofilm growth at 37°C and 30°C in either LB or HTM medium, 37°C and HTM, 
minimal medium were finally selected as the standard conditions for the subsequent 
microtiter plate assays, because bacteria had the most robust biofilm growth under these 
conditions. As shown in Figure 4-1, regardless of the temperature, HTM medium 
promotes better biofilm growth than LB medium, while 37°C is better than 30°C no 
matter which medium was used. 
Selection of biofilm abnormal mutants 
          A total of 10,000 mutants were generated through transposon mutagenesis. The 
biofilm formation ability of these mutants were compared with the wild type 10403S 
strain and the flaA in-frame deletion mutant in HTM, the minimal medium in 96-well 
polystyrene plates. Under our test conditions, the OD.570 of the 10403S biofilm after 48 
h incubation generally was around 1.40, while the OD.570 of flaA mutant was around 
0.70. 14 mutants were selected for at least 50% decrease biofilm formation compared 
with the 10403S, and biofilm formation of 4 mutants were shown in Figure 4-2. The 
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growth rates of these 14 mutants were studied in both BHI and HTM medium, and none 
of them showed any growth defect compared with the wild type 10403S. Southernblot 
revealed the single transposon insertion in these mutants, and linkage test showed that the 
biofilm defects of these mutants indeed linked with the transposon insertion.  
Identification of transposon locations 
          By arbitrary-primed PCR and sequence analysis in NCBI Nucleotide data base, the 
transposon location in these 14 mutants were successfully identified. In some mutants the 
transposon inserted in the open reading frame of genes, while in others it located between 
adjacent open reading frames. The transposon location in 3 mutants were shown in Figure 
4-3,4-4, 4-5 and the descriptions of these genes were summarized in Table 4-1.  
The  role of lmo1083, lmo1256, lmo2553 & lmo2554 in biofilm formation 
          In Tm-6 mutant, the transposon located at the end of the open reading frame of the 
gene lmo2554 between 916 bp and 917 bp. Because there are only 6 bp between the open 
reading frame of the gene lmo2554 and lmo2553, this transposon insertion probably 
would affect the transcription of both lmo2554 and lmo2553 since these two genes are 
normally co-transcribed. Thus in-frame deletion mutant of both genes were constructed, 
and tested for biofilm growth in polystyrene tubes. In HTM medium, a reproducible 
defect compared with the wild type was observed among all the three time points tested 
with ∆lmo2554 strain (Figure 4-7), with a 87% decrease at 24 h, a 96% decrease at 48 h 
and 72 h. Biofilm of ∆lmo2553 strain decreased as well, with a 84% reduction at 24 h, a 
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75% reduction at 48 h and 72 h (Figure 4-7). To collect the biofilm growth information 
from different medium, biofilm growth of constructed deletion mutants were also tested 
in LB medium. In LB medium biofilm of ∆lmo2554 strain had a 70% decrease at 24 h 
and 72 h, and a 53% decrease at 48 h compared with the wild type (Figure 4-6), while 
biofilm of the ∆lmo2553 strain had about a 45% reduction at 24 h, 48 h and 72 h (Figure 
4-6).  
          In addition to these two, in-frame deletion mutant of other two genes, lmo1083 
encoding a protein similar to dTDP-D-glucose 4,6-dehydratase, and lmo1256 encoding a 
hypothetical protein, were also constructed. These two genes were identified from other 
project. Biofilm test of these two mutants were performed with HTM and LB medium. 
Interestingly ∆lmo1083 strain had a similar biofilm growth pattern as the wild type in 
HTM medium (Figure 4-7), while in LB medium the absence of lmo1083 led to a 77% 
decrease at 24 h, a 37% decrease at 48 h and a 51% decrease at 72 h (Figure 4-6). 
Absence of lmo1256 did not affect the biofilm formation in LB or HTM medium. Thus 
lmo1083 might also play a role in L. monocytogenes biofilm formation, and this effect 
might relate to the specific medium used.  
PrfA and virulence genes in biofilm 
          Biofilm of the PrfA mutant and other virulence genes mutants were also compared 
with the wild type strain 10403S in LB and HTM medium. As shown in Figure 4-8, the 
absence of PrfA and other virulence genes had a minimal effect on biofilm growth in LB. 
But in HTM medium (Figure 4-9), deletion of PrfA led to a 70% biofilm reduction at 24 
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h, and a 40% reduction at both 48 h and 72 h. Most of the tested virulence mutants had a 
similar biofilm level as the wild type, except for the plcA- plcB- double mutant and mpl- 
mutant (Figure 4-9). Absence of plcA and plcB resulted in a similar 40% biofilm 
reduction as that of the prfA- mutant at 48 h and 72 h, but only minimal decrease was 
observed at 24 h. A 50%, 66%, and 80% decrease at 24 h, 48 h and 72 h respectively was 
observed for the mpl- mutant.   
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Figure 4-1. Average biofilm growth of the wild type 10403S strain from 3 parallel repeats 
in LB and HTM medium in 96-well polystyrene plates at 37°C and 30°C after different 
incubation periods.   
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Figure 4-2. Average 3-day biofilm formation of several transposon mutants from 3 
parallel repeats in HTM medium in 96-well polystyrene  plates. 
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Figure 4-3. Transposon location in mutant TM-2, which led to the identification of the 
genes lmo1262 and lmo1263. The symbol represents the terminator. The symbol  
represents the location of the transposon, and the direction represents the orientation of 
the erythromycin resistance cassette in the transposon.  
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Figure 4-4. Transposon location in mutant TM-6, which led to the identification of the 
genes lmo2553 and lmo2554. The symbol represents the terminator. The symbol  
represents the location of the transposon, and the direction represents the orientation of 
the erythromycin resistance cassette in the transposon.  
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Figure 4-5. Transposon location in mutant TM-16, which led to the identification of the 
gene lmo0707. The symbol represents the terminator. The symbol   represents the 
location of the transposon, and the direction represents the orientation of the 
erythromycin resistance cassette in the transposon.  
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Table 4-1. Identified genes through transposon localization in this study.  
 
  
Gene Description 48 h Defect
lmo0734   Similar to transcriptional regulator (LacI family) 3.1
lmo1262 similar to transcriptional regulator(phage-related) 4
lmo1263 similar to transcriptional regulator 4
lmo2553 hypothetical protein 5.6
lmo2554 similar to galactosyltransferase 5.6
lmo0106   DltD protein for D-alanine esterification of lipoteichoic 7.6
lmo0644
  LTA synthesis, Transfer initial glycerolphosphate to form
             dGroP-Gal-Glc-DAG 
6.8
lmo1370   Similar to branched chain fatty acid kinase 50
lmo2229   Similar to penicillian- binding protein 5.4
lmo2205   Similar to phosphoglyceromutase1 3.6
lmo0086   Phosphoribosylformylglycinamidine synthetase I 17.9
lmo2534   AtpE 12.2
lmo2535   AtpB 14.9
lmo2529   AtpD 4.4
lmo0685   Flagella biosysthesis protein 4.8
lmo0707   Flagellar FliD 2
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Figure 4-6. Average biofilm formation of the in-frame deletion mutants from 3 parallel 
repeats in LB medium in polystyrene tubes compared with the wild type 10403s and 
∆flaA strain. 
  
0
0.1
0.2
0.3
0.4
0.5
0.6
O
D
.6
0
0
strains
biofilm in LB,tube
24 h
48 h
72 h
40 
 
 
 
 
 
Figure 4-7. Average biofilm formation of the in-frame deletion mutants from 3 parallel 
repeats in HTM medium in polystyrene tubes compared with the wild type 10403s and 
∆flaA strain. 
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Figure 4-8. Average biofilm formation of the PrfA mutant and virulence mutants from 3 
parallel repeats in LB medium in polystyrene tubes compared with the wild type 10403s 
strain.  
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Figure 4-9. Average biofilm formation of the PrfA mutant and virulence mutants from 3 
parallel repeats in HTM medium in polystyrene tubes compared with the wild type 
10403s strain. 
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CHAPTER FIVE 
DISCUSSION 
          The adapted ability of biofilm formation can dramatically facilitate the bacterial 
transmission and infection. L. monocytogenes has been demonstrated to be capable of 
biofilm growth, which definitely increases its survival opportunity and chances to cause 
serious infections. Although several groups have identified a few functional 
molecules[52,57,73] that play critical roles in L. monocytogenes biofilm development,  
transcriptomic[125,126] and proteomic[127-129] studies on other species have also been 
carried out to generate comprehensive views of this process. It’s a very complicated 
phenomenon affected by so many factors that currently a well-understood network is still 
lacking. In this study, a genome-wide screening for the functional factors involved in L. 
monocytogenes biofilm was performed through mariner transposon mutagenesis in 
combination with microtiter plate assays. The mariner transposon was initially 
constructed based on Himar 1 mariner, and modified specially for the transposition in 
low GC content Gram-positive microorganisms[114] with advantages including high 
transposition efficiency, good randomness, and low plasmid retention rate[114]. From 
10,000 mutants screened, 14 were selected for an at least 50% reproducible biofilm 
defects comparing with the wild type. The growth rate of these 14 mutants was compared 
with the wild type, and none of them showed any growth defect, excluding the possibility 
of impaired growth of these mutants in our tests. The linkage test results suggested that 
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the transposon insertion in the bacterial chromosome is responsible for the observed 
biofilm defects.  
          The transposon insertion site in the 14 mutants were identified, and the genes 
involved were categorized into 5 different functional groups as shown in table 3-1, 
including transcriptional regulation, bacterial cell wall synthesis, flagella assembly, ATP 
formation and metabolism.   
          A big group of genes we’ve identified relates to cell wall components biosynthesis, 
especially lipoteichoic acid (LTA). LTA is a secondary wall polymer that consists of the 
cell wall of Gram positive bacteria with peptidoglycan, proteins, and capsular 
polysaccharides[130]. Normally LTA has a basic structure in which a poly-
glycerolphosphate chain linked with the membrane glycolipid[131]. It is known that the 
glycerolphosphate in L. monocytogenes could be substituted by glycosyl residues or D-
alanine esters[131]. LTA is a macroamphiphile molecule which by its electric charge 
properties exerts several functions in the Gram positive bacteria, including protection 
against environmental stress[132], regulation of cation concentration in the cell wall[133], 
and interaction with host cells[134], while D-alanylation of LTA directly relates to the 
electric charge properties of this polymer. LTA is an anionic polymer, and the D-alanine 
ester formation requires the anionic glycerolphosphate group and the cationic D-alanine 
group. The D-alanine ester content was suggested to determine the number of available 
anionic sites on LTA for binding with other cationic substances[133], such as autolysins, 
the enzymes catalyzing the hydrolysis of covalent bonds in the peptidoglycan of cell 
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wall[135]. So it seems like without functional D-alanine ester more autolysins would be 
able to bind to the LTA, and result in increased autolysis. This idea possibly explains the 
identification of the gene lmo0106 in our study. lmo0106 encodes the DltD protein for D-
alanine esterification of LTA. It’s reasonable that insertion mutation of DltD jeopardized 
the D-alanine ester substitution of LTA, which subsequently led to increased autolysins 
binding to the LTA in the mutant, increased cell lysis and reduced cell number in the 
biofilm community. A similar autolysis up-regulation was observed in Lactobacillus 
rhamnosus D-alanylation mutant[133].  
          Other genes in this group include lmo1370 encoding a branched chain fatty acid 
kinase that transfers a phosphate group from the ATP to 2-methylpropanoate, lmo2229 
encoding a penicillin-binding protein which is involved in peptidoglycan biosynthesis, 
lmo2553 encoding a hypothetical protein, lmo2554 encoding a galactosyltransferase 
which is responsible for the glycolipid anchor production of LTA[131], and lmo0644 
encoding the LTA primase that mediates the transfer of initial glycerolphosphate to the 
glycolipid [131]. Huebner’s group recently discovered that the glycolipids of 
Enterococcus faecalis is involved in biofilm formation[136]. The putative 
glucosyltransferase mutant exhibited significant alteration of membrane glycolipid profile 
and failed to accumulate in growing biofilm, although the initial adhesion was not 
affected[136]. LTA synthesis was proven to be required for S.aureus growth at 
37°C[137], and the destruction of polyglycerolphosphate synthase resulted in aberrant 
cell division and separation[137]. In our study, it seems like the LTA is required for L. 
monocytogenes biofilm formation. In-frame deletion of lmo2554 resulted in a around 90% 
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biofilm reduction while in-frame deletion of lmo2553 led to a around 80% biofilm 
reduction at 37°C in HTM medium. In LB medium the biofilm reduction effect due to the 
absence of these two genes was not as significant as in HTM medium. To further support 
the role of cell wall components in L. monocytogenes biofilm, deletion mutants of the 
other identified genes should be tested for biofilm growth, and the respective genetic 
complementation should be performed as well to confirm their involvements.  
          Three transcriptional regulators were identified in our test. In the TM-1 transposon 
mutant, the transposon located at the 150 bp intergenic region between lmo1262 and 
lmo1263. The transposon inserted between 32 bp and 33 bp upstream of lmo1262. It’s 
possible that this insertion probably affected the promoter function and the subsequent 
transcription of both genes. lmo1262 encodes a phage-related transcriptional regulator. 
Bioinformatic analysis of the protein sequence indicates that it is a phage λ repressor-like 
DNA binding protein. λ repressor DNA binding protein controls the expression of viral 
genes involved in lysogeny/lytic growth switch. This type of repressor is essential for 
maintaining the lysogeny cycle, and lytic growth is only induced when the host cell is 
threatened. It usually contains two domains connected by a linker: an N-terminal DNA-
binding domain which also mediates the interaction with RNA polymerase, and a C-
terminal dimerisation domain. The HTH motif of Lmo1262 locates at the N-terminal 
from 5th to 63rd amino acid. Analysis of lmo1263 suggests that it also encodes a HTH-
XRE transcriptional regulator, but is not phage-related. The HTH motif locates from 13th 
amino acid to 69th amino acid. lmo0734 encodes a PurR transcriptional regulator, the N-
terminal of which contains a HTH binding domain of Lac I family transcriptional 
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regulator. It was well proved that PurR and Lac I family transcriptional regulators have 
highly homologous secondary and tertiary structure[138]. This probably implies that the 
Lmo0734 regulator binds to DNA via its N-terminal domains to repress downstream gene 
transcription, and this repression can be retrieved through the interaction with a small 
effector ligand in a cleft of core N- and C-terminal intermediate region. The identification 
of the downstream genes regulated by these transcriptional regulators will reveal more 
valuable information about the underlying mechanisms of L. monocytogenes biofilm. 
Chromatin immune-precipitation (CHIP) based on the affinitive interaction between 
transcriptional regulator and its antibody could be a good method to pursue for this 
purpose.  
          Flagellum is a tail-like structure protruding from the cell body that generally 
mediates the bacterial extracellular movement. Flagellum biosynthesis plays an important 
role in L. monocytogenes extracellular motility, and several groups have reported 
different roles of flagellum in L. monocytogenes biofilm development. Though flagellum 
was generally considered as essential during the whole biofilm developmental 
process[52], Young’s group did provide different evidences supporting the idea that 
flagellum was only required for the initial cell attachment, and absence of flagellum led 
to a final increased biofilm growth[53]. The two genes identified in our study actually 
function in different aspects of flagellum. lmo0685 encodes a flagellum biosynthesis 
protein similar to MotA, which with MotB together forms the ion channels that couple 
flagellar rotation to the proton motive force across the membrane[139]. MotA mutation 
should destroy the ion channels to some extent and probably cut off the rotor power for 
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flagella rotations. Identification of this gene indicates that flagellar motility might be 
required for L. monocytogenes biofilm growth in our conditions. The other gene lmo0707 
encodes the flagellar hook-associated protein FliD. This protein contributes to the flagella 
functions by facilitating the polymerization of the flagellin monomers at the tip of 
growing flagellum filament. FliD forms a cap-like structure, which prevents the flagellin 
subunits from slipping out without polymerization at the end. Thus destroying the FliD 
was expected to jeopardize the formation of regular flagellum tail. It seems like the 
flagella tail-like structure is also involved in L. monocytogenes biofilm growth. It was 
well documented that flagellum biosynthesis is dramatically shut down when the 
bacterium senses the intracellular signal, such as 37°C which is the normal human body 
temperature. Initially in this study various biofilm growth conditions were tested for 
selection of optimal combination for biofilm growth, and 37°C reproducibly yielded 
better biofilm growth than 30°C. This probably suggests that a tiny amount of flagellum 
is enough for biofilm growth in our test condition.  
          lmo2205 which encodes a protein similar to phosphoglyceromutase 1 was 
identified in our screening. Phosphoglyceromutase catalyzes the inter-conversion of 2-
phosphoglycerate and 3-phosphoglycerate, and it’s generally involved in carbohydrate 
degradation and glycolysis. Another identified gene is lmo0086, which encodes the 
phosphoribosylformylglycinamidine synthetase I. This enzyme catalyze the production of 
ADP, phosphate, 2-(formamido)-N(1)-(5-phospho-D-ribosyl) acetamidine, and L-
glutamate from a combination of substrates including ATP, N(2)-formyl-N(1)-(5-
phospho-D-ribosyl) glycinamide, L-glutamine and H2O. lmo1083  encoding a dTDP-D-
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glucose 4,6-dehydratase was identified in other project, and was found to involve in 
biofilm formation in LB medium, since absence of this gene led to reduced biofilm in LB 
medium, but not in HTM medium. It’s possible that some ingredients from the LB 
complex medium specifically influence the sugar metabolism, and require the dTDP-D-
glucose 4,6-dehydratase to assume a normal biofilm development. More information is 
needed to further characterize the role of these three genes in biofilm formation, 
considering that carbohydrate metabolism could possibly affect several aspects, such as 
bacterial physiology and matrix production, which could be relevant to normal biofilm 
growth.  
          Another group of genes identified in our screening includes lmo2534, lmo2535 and 
lmo2529, all of which encode a subunit of ATP synthase. ATP is the primary energy 
supplier for most physiological and biochemical activities. Thus blocking ATP 
biosynthesis could interfere a lot of biological functions, including biofilm formation. It’s 
noteworthy that the transposon mutants from this group did not show any growth defect. 
This might be due to the redundant functions of other subunits in the ATP synthase.  
          Interestingly in our screening, we haven’t identified any increased biofilm mutant. 
Neither did we find any gene previously proven to mediate L. monocytogenes biofilm. 
Our bioinformatic study indicated that there are some homologues of B. subtilis proteins 
which have been shown to regulate biofilm, such as lmo0168 that shares 60% identity 
with the AbrB repressor, or lmo0806 that shares 35% identity with SinR repressor. No 
such homologue was turned up during our screening either. One possible reason for this 
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flaw is that among the 10,000 mutants we have screened several could be siblings, thus 
we actually need to screen more mutants to fully cover the whole genome of L. 
monocytogenes. The test conditions we adopted could be another possible reason. 
Biofilm formation is the type of microbial activity that closely relates with its 
surrounding environment. A minor variation in the test condition could lead to big 
differences in the results. The third possibility is that those essential genes which might 
also affect biofilm formation would not be found in our screening due to the limits of the 
method we used.  
          It was recently reported that besides mediating the transition from an extracellular 
free-living style to an intracellular pathogen, the master regulator of L. monocytogenes 
virulence, PrfA also contributes to normal biofilm growth[41]. Besides the genome-wide 
screening for functional factors in L. monocytogenes biofilm, we also tried to probe the 
role of PrfA in biofilm. Consistent with the reported result, deletion of PrfA led to a 
dramatic reduction in biofilm formation in minimal medium, while constitutive 
expression of PrfA had minimal effect. Surprisingly different from the reported, two 
virulence mutants, plcA-plcB- double deletion mutant and mpl mutant, showed obvious 
biofilm defects in our study. The biofilm reduction for plcA-plcB- double mutant was 
similar to that of the PrfA mutant at 48 h and 72 h, while the reduction of mpl mutant was 
even more significant than that of the PrfA and double mutant. It would be interesting to 
investigate whether the contribution of PrfA in biofilm is related with its regulatory effect 
on the virulence genes, or other unidentified factors. mpl encodes the zinc 
metalloprotease which is responsible for the maturation of the broad-range phospholipase 
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C (PC-PLC) encoded by plcB. It contributes to L. monocytogenes virulence by cleaving 
the N-terminal signal peptide of PC-PLC. This cleavage activates the PC-PLC enzyme 
activity that is important for bacterial escape from the vacuole. If Mpl contributes to 
biofilm growth only by function of PC-PLC, a similar defect of mpl- mutant and plcB- 
mutant would be expected. However the variation between our mpl- mutant and plcA-
plcB- double mutant seems to indicate that Mpl might have another downstream target, 
and this target also plays a role in biofilm growth. It will be more valid to compare the 
biofilm formation of plcB- mutant with mpl- mutant. Also it will be interesting to look at 
whether the enzyme activity of PC-PLC is required for biofilm or not. 
          In conclusion, we identified 16 genes that are possibly involved in L. 
monocytogenes biofilm formation by transposon mutagenesis in combination with 
microtiter plate assay. These genes play a role in bacterial transcriptional regulation, cell 
wall synthesis, flagella assembly, ATP formation or metabolism. The detailed functions 
of these genes in biofilm development await further study through the non-polar mutants 
and the signal pathways involved. This study will generate several valuable information 
about the molecular basis of L. monocytogenes biofilm formation, which will eventually 
help with the identification and development of drug targets for biofilm eradication.  
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